Vishal A. Verma

发表

Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.

Christian Gampe, Vishal A. Verma, Christian M. Gampe, 2020, Journal of medicinal chemistry.

5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.

X. Tong, M. Maccoss, R. Reynolds, 2012, Bioorganic & medicinal chemistry letters.

Beyond Natural Products: Synthetic Analogues of Bryostatin 1

Vishal A. Verma, P. Wender, J. Baryza, 2006 .

The cryptophycins as potent payloads for antibody drug conjugates.

S. Spencer, Vishal A. Verma, G. Phillips, 2015, Bioorganic & medicinal chemistry letters.

A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Aβ-induced biomarker abnormality on cultured fibroblasts

D. Alkon, Vishal A. Verma, P. Wender, 2009, Neurobiology of Disease.

Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody-Drug Conjugates.

R. Rowntree, James Lee, D. Stokoe, 2018, Molecular pharmaceutics.

Discovery of Inhibitors of the Lipopolysaccharide Transporter MsbA: From a Screening Hit to Potent Wild-Type Gram-Negative Activity.

Benjamin D. Sellers, Jun Liang, C. Koth, 2022, Journal of medicinal chemistry.

Actin is the primary cellular receptor of bistramide A

Vishal A. Verma, P. Wender, J. Baryza, 2005, Nature chemical biology.

Function-oriented synthesis, step economy, and drug design.

Paul A Wender, Vishal A Verma, Thomas J Paxton, 2008, Accounts of chemical research.

The double addition reaction of alkoxymethyl nucleophiles to esters to generate novel polyoxygenated species

Vishal A. Verma, A. Arasappan, F. G. Njoroge, 2010 .

Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells

J. Menéndez, R. Lupu, E. Atlas, 2004, Oncogene.

Total synthesis and initial biological evaluation of new B-ring-modified bryostatin analogs.

Paul A Wender, Vishal A Verma, Vishal A. Verma, 2006, Organic letters.

Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her‐2/neu (erbB‐2) oncogene‐induced malignant transformation

J. Menéndez, R. Lupu, Vishal A. Verma, 2004, Molecular carcinogenesis.

Discovery of Peptidomimetic Antibody-Drug Conjugate Linkers with Enhanced Protease Specificity.

S. Steinbacher, BinQing Wei, C. Eigenbrot, 2017, Journal of medicinal chemistry.

Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity

Vishal A. Verma, P. Wender, J. Baryza, 2011, Proceedings of the National Academy of Sciences.

Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatin.

Vishal A. Verma, P. Wender, 2006, Organic letters.

Function‐Oriented Synthesis, Step Economy, and Drug Design

Paul A. Wender, Vishal A. Verma, P. Wender, 2008 .

A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment

Simon S. Gao, J. Elstrott, M. Volgraf, 2021, The Journal of experimental medicine.

Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death

L. Delang, J. Neyts, Vishal A. Verma, 2016, Journal of natural products.

2′-Modified Guanosine Analogs for the Treatment of HCV

Q. Dang, A. Stamford, Vishal A. Verma, 2016, Nucleosides, Nucleotides & Nucleic Acids.

Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling.

C. Brotherton-Pleiss, M. Volgraf, Jun Chen, 2018, Journal of medicinal chemistry.

α-Aryl pyrrolidine sulfonamides as TRPA1 antagonists.

Jun Chen, D. Hackos, J. Lyssikatos, 2016, Bioorganic & medicinal chemistry letters.

The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinity.

Paul A Wender, Vishal A Verma, Vishal A. Verma, 2008, Organic letters.

Synthesis and SAR of geminal substitutions at the C5' carbosugar position of pyrimidine-derived HCV inhibitors.

X. Tong, M. Maccoss, N. Bansal, 2012, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors.

X. Tong, M. Maccoss, N. Bansal, 2012, Bioorganic & medicinal chemistry letters.

A Review on Pharmacological Aspects of Pyrimidine Derivatives

A. Agarwal, Vishal A. Verma, Udichi Kataria, 2020 .

Discovery of Selective Tertiary Amide Inhibitors of Cyclin-Dependent Kinase 2 (CDK2).

J. Grandner, Steffan Vartanian, John G. Moffat, 2023, ACS medicinal chemistry letters.

The cryptophycins as potent payloads for antibody drug conjugates.

S. Spencer, Vishal A. Verma, G. Phillips, 2015, Bioorganic & medicinal chemistry letters.

Organic Synthesis Toward Small-Molecule Probes and Drugs Special Feature: Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity

Vishal A. Verma, P. Wender, J. Baryza, 2011 .